Pemazyre™ (pemigatinib) for the Treatment of Cholangiocarcinoma
Pemigatinib is an inhibitor of the fibroblast growth factor receptor (FGFR1, 2 and 3). Credit: Incyte Corporation.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more